Resource Center
Welcome to our resource center, your comprehensive hub for valuable information and insights in the field of diagnostic testing and precision medicine. As a leading global provider of specialized laboratory testing services, we understand the importance of staying informed and up-to-date in the ever-evolving world of healthcare diagnostics. The resource center is available to empower healthcare professionals, researchers, and industry stakeholders by offering a wide range of educational materials including; whitepapers, case studies, podcasts, videos, e-books and webinars. Whether you are seeking in-depth knowledge about cutting-edge diagnostic technologies, exploring emerging trends in precision medicine, or looking for practical guidance on test interpretation and patient care, our resources center is your go-to destination for reliable and relevant information. Join us on this journey of discovery and innovation as we strive to enhance patient outcomes and advance the field of diagnostic testing together.
Watch the on-demand webinar where we’ll examine the diagnostic challenges of endemic mycoses, including histoplasmosis and coccidioidomycosis. Learn how emerging tools are helping overcome limitations in identifying dimorphic fungi and improving outcomes in invasive fungal infections. The session features expert insights and a live Q&A. Don’t miss this opportunity to advance your understanding of fungal diagnostics.
Now available on-demand: A case-based webinar on non-tuberculous mycobacterial (NTM) PCR testing, exploring its clinical implications and practical applications. Discover how rapid PCR testing has advanced the detection and management of NTM infections. Dr. Mirza Haider Ali shares real-world insights into how timely, accurate diagnostics can support earlier intervention and improve patient outcomes.
Eurofins Viracor’s white paper details the analytical validation of a hybrid capture sequencing assay for detecting invasive fungal and bacterial infections (IFBIs) from plasma and BAL samples. The assay demonstrated high sensitivity and specificity, with strong concordance to qPCR results and reduced polymicrobial reporting. This targeted approach enhances diagnostic accuracy and interpretability, especially for immunocompromised patients.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.